The Generic Drug Price-Fixing Scandal: Recent Developments in the Federal and State Investigations and Parallel Civil Litigation Authors of this newsletter: Matthew Mustokoff , Joshua Materese , Jonathan Neumann , Evan Hoey The importance of generic drugs to the U.S. healthcare system cannot be overstated. Generic drugs have long been referred to […] Read More
Pitfalls of Relying on Many Third Party Service Providers in Non-US Litigation Authors of this newsletter: Emily Christiansen Many third party claims filing service providers offer services to clients for shareholder litigation outside the U.S. where an investor […] Read More
The Delaware Supreme Court Reinstates Claims of Former Towers Watson Stockholders Authors of this newsletter: On June 30, 2020, Kessler Topaz convinced the Delaware Supreme Court to reinstate stockholders’ claims for breaches of fiduciary duty […] Read More
KTMC Investigates Whether Wayfair Inc. Insiders Took Advantage Of Economic Uncertainty Caused By COVID-19 Authors of this newsletter: Matthew Benedict The arrival of the COVID-19 epidemic in North America late this winter took the global economy by surprise. The lack […] Read More
Pending Third Circuit Appeal on Equitable Tolling Implicates Class Members’ Ability to Bring Individual Actions Authors of this newsletter: Karissa Sauder , Ryan Degnan The Third Circuit is slated to hear argument in Aly v. Valeant Pharmaceuticals International, Inc., No. 19-3326, which presents the […] Read More
First Circuit Upholds Ability of Securities Classes to Add Named Plaintiffs Authors of this newsletter: Geoffrey Jarvis There is a split among the Federal Courts of Appeals as to whether a plaintiff in a class action whose […] Read More
Judge Grants Final Approval to $120 Million Settlement Ending Seven-Years of Litigation in In re Loestrin 24 Fe Antitrust Litigation Authors of this newsletter: Terence Ziegler On September 1, 2020, Judge William E. Smith of the United States District Court for the District of Rhode Island […] Read More
